We are a UK based healthcare company that researches and develops innovative, quality, cost-effective products that will improve the health and wellbeing of people around the world. We strongly believe that working in partnership helps us to achieve more, and so we work closely with other companies, the NHS and the academic sector to improve health outcomes.
We have been awarded ISO 13485:2016, an internationally recognised quality standard for our medical devices, which illustrates the importance that we place on ensuring our medical devices meet client and regulatory requirements.
At Fontus Health we have an expanding, diverse portfolio of products with a strong pipeline covering a wide range of treatment areas including mental health, analgesia, cardiology, dermatology, respiratory, urology and oncology.
Gentle enough to be used from birth upwards, the complete AproDerm® range of emollients and barrier creams have been developed to be suitable for patients suffering from eczema, psoriasis and other dry skin conditions.
For the management of breakthrough cancer pain in patients already receiving maintenance opioid therapy. Cynril® Lozenges are available in six strengths ranging from 200mcg to 1600mcg.
Indicated for the treatment of acute promyelocytic leukaemia (APL) and acute myeloid leukaemia M3 (AML M3) in adults, adolescents and children. Hanixol® is available in a strength of 50mg.
Extended release capsules indicated for the symptomatic treatment of mild to moderately severe Alzheimer type dementia.
Indicated for the treatment of bipolar disorder and schizophrenia, Zaluron® XL Tablets are available in 50mg, 150mg, 200mg, 300mg and 400mg strengths.
The Fontus Health range of products offers significant potential savings for CCGs and practices against market-leading brands.
Please note that Fontus Health cannot answer any questions about your medical condition or give any health advice. If you have any concerns about a personal medical condition, please consult a healthcare professional.
To report a suspected adverse event to one of our products or to discuss a specific product enquiry either:
Call: +44 (0) 121 661 4615 or Email: [email protected]
Information on adverse event reporting to the UK Health Authority can be found at yellowcard.mhra.gov.uk
